Ankit Gupta

Ankit Gupta

Active Director Whole-Time Director DIN 08015587
DIN 08015587 First appointment Jun 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 4 historical roles
Total affiliations 10 Since Jun 2018
Shareholding value •••• Premium profile

About Ankit Gupta

Data last updated:

Ankit Gupta is a Whole-Time Director at Instapill Private Limited (since 2025), Director at Pharma Platforms Private Limited (since 2026) and Director at Dvise Pharma Tech Private Limited (since 2026), and holds 3 more current directorships. The companies operate in Pharma, Healthcare and Business Outsourcing. The largest current company by reported revenue is Instapill Private Limited at ₹101 Cr (FY 2025). Earlier, Ankit Gupta was a Director at Biolexis Private Limited (2022–2023) and Director at Strides Pharma Services Private Limited (2022–2023) and 2 more.

DIN 08015587
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 08 Jun 2018
Oldest Company Age 19 yrs
Largest company Instapill Private Limited · ₹101 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Instapill Private Limited U24230KA2007PTC042337
Whole-Time Director11 Feb 20252007₹101 Cr (FY 2025)Active
Pharma Platforms Private Limited U21001KA2026PTC227870
Director15 Sep 20262026Active
Dvise Pharma Tech Private Limited U21001KA2026PTC214441
Director19 Jan 20262026Active
Serovia Pharma Private Limited U21001KA2025PTC205529
Director24 Oct 20252025Active
Dvise Medtech Private Limited U21000KA2025PTC206269
Director05 Aug 20252025Active
Designated Partner08 Jun 20182018Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biolexis Private Limited U24239KA2022PTC156696
Director17 Jan 20222022₹1.87 Cr (FY 2025)Active
Director11 Jul 20222022Active
Steribrooks Penems Private Limited U24232KA2020PTC135017
Director18 Jun 20202020₹13.2 Lakh (FY 2023)Under Process Of Striking Off
Director29 Aug 20202020₹9.53 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ai Cue Capital Llp
Dvise Pharma Tech Private Limited
Serovia Pharma Private Limited
Dvise Medtech Private Limited
Premium access

Shareholding and investment profile for Ankit Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankit Gupta

Ankit Gupta currently holds 6 directorships: Instapill Private Limited (Whole-Time Director, since 11 Feb 2025, revenue ₹101 Cr (FY 2025)); Pharma Platforms Private Limited (Director, since 15 Sep 2026); Dvise Pharma Tech Private Limited (Director, since 19 Jan 2026); Serovia Pharma Private Limited (Director, since 24 Oct 2025); Dvise Medtech Private Limited (Director, since 05 Aug 2025); and 1 more.

Ankit Gupta was first appointed on 08 Jun 2018 as Designated Partner at Ai Cue Capital Llp. The most recent appointment on record is 15 Sep 2026 at Pharma Platforms Private Limited.

Ankit Gupta held 4 earlier board appointments: Biolexis Private Limited (Director, 17 Jan 2022 to 26 Jul 2023); Strides Pharma Services Private Limited (Director, 11 Jul 2022 to 06 Jul 2023); Steribrooks Penems Private Limited (Director, 18 Jun 2020 to 01 Oct 2020); Steriscience Specialties Private Limited (Director, 29 Aug 2020 to 05 Nov 2020).

The current boards of Ankit Gupta's companies include Gopakumar Gopalan Nair (Instapill Private Limited), Gunashekar Karthik (Instapill Private Limited), Guruswamy Pendyala (Instapill Private Limited), Rajashri Santosh Kumar Ojha (Instapill Private Limited), Venkataraman Subramanian Iyer (Instapill Private Limited), Aditya Arun Kumar (Pharma Platforms Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available